NCT00273013
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Manchester, Lancashire, United Kingdom
- GSK Investigational Site London, United Kingdom
Clinical trial condition
Asthma
Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.
2,962 public trials
170 recruiting studies
Asthma trial results
NCT02975258
- Conditions
- Adiposity, Asthma, Body Weight, +17 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT02719379
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01514760
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
Completed
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
NCT02586506
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Aventura, Florida, United States
- GSK Investigational Site Miami, Florida, United States
Completed
A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
NCT01730027
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Pulmagen Investigational Site Birmingham, Alabama, United States
- Pulmagen Investigational Site Huntington Beach, California, United States
- Pulmagen Investigational Site Riverside, California, United States
- Pulmagen Investigational Site Rolling Hills, California, United States
NCT01573624
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site St Louis, Missouri, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Orangeburg, South Carolina, United States
- GSK Investigational Site Spartanburg, South Carolina, United States
NCT02405026
- Conditions
- Asthma, Bronchial Diseases, HIV, +7 more
- Locations
-
- Duke Asthma Allergy and Airway Center Durham, North Carolina, United States
Completed
Denver Health Asthma Management Program
NCT02860390
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
Completed
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
NCT01147744
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site San Diego, California, United States